In life sciences (40% of sales), Bio-Rad sells various life sciences tools used by research labs, biopharmaceutical manufacturers, and food testers. Example products include western blot machines ...

Bio-Rad Laboratories, Inc. (NYSE:BIO) shareholders are probably feeling a little disappointed, since its shares fell 2.6% to US$236 in the week after its latest quarterly results. Overall the ...

Jonathan DiVincenzo; President, Chief Operating Officer; Bio Rad Laboratories Inc Roop Lakkaraju; Chief Financial Officer, Executive Vice President, Principal Financial officer; Bio Rad ...

Bio-Rad Laboratories (NYSE:BIO) is set to give its latest quarterly earnings report on Thursday, 2025-05-01. Here's what investors need to know before the announcement. Analysts estimate that Bio ...

HERCULES, Calif. (AP) — HERCULES, Calif. (AP) — Bio-Rad Laboratories Inc. (BIO.B) on Thursday reported first-quarter earnings of $64 million. On a per-share basis, the Hercules, California ...

Bio-Rad reported a year-on-year decline in revenue of 1.5% at constant currency, primarily due to weak equipment sales in life sciences due to low demand from the academic research market.

My name is Desyree, and I will be your conference operator today. At this time, I would like to welcome everyone to the Bio-Rad First Quarter 2025 Earnings Results Conference Call and Webcast.

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through ...

The BlotCycler automates western blot development and processing. BlotCycler, automated western processor, will process the blot through all washing, blocking, and incubation steps. Once the ...